124 related articles for article (PubMed ID: 25633990)
1. Expression of cytokeratins in glioblastoma multiforme.
Terada T
Pathol Oncol Res; 2015 Jul; 21(3):817-9. PubMed ID: 25633990
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study.
Oh D; Prayson RA
Arch Pathol Lab Med; 1999 Oct; 123(10):917-20. PubMed ID: 10506444
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
4. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
5. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.
Naka T; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
Mod Pathol; 1997 Jun; 10(6):545-51. PubMed ID: 9195570
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin expression profile in gastric carcinomas.
Kim MA; Lee HS; Yang HK; Kim WH
Hum Pathol; 2004 May; 35(5):576-81. PubMed ID: 15138932
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytokeratins in gliomas.
Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of cytokeratins in amyloid deposits associated with squamous cell carcinoma and dysplasia in the oral cavity, pharynx and larynx.
Ueno T; Hoshii Y; Cui D; Kawano H; Gondo T; Takahashi M; Ishihara T
Pathol Int; 2003 May; 53(5):265-9. PubMed ID: 12713559
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma multiforme versus pleomorphic xanthoastrocytoma with anaplastic features in the pathological diagnosis: a case report.
Yamada SM; Murakami H; Tomita Y; Nakane M; Shibui S; Takahashi M; Kawamoto M
Diagn Pathol; 2016 Jul; 11(1):65. PubMed ID: 27449352
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Expression of Different Subtypes of Cytokeratins by Endometrial Stromal Sarcoma.
Rahimi S; Akaev I; Marani C; Chopra M; Yeoh CC
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):466-470. PubMed ID: 29406332
[TBL] [Abstract][Full Text] [Related]
13. Transcription of cytokeratins 8, 18, and 19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: inherent limitations for RT-PCR in the detection of isolated tumor cells.
Dimmler A; Gerhards R; Betz C; Günther K; Reingruber B; Horbach T; Baumann I; Kirchner T; Hohenberger W; Papadopoulos T
Lab Invest; 2001 Oct; 81(10):1351-61. PubMed ID: 11598148
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of expression of cytokeratin subtypes in squamous cell carcinoma of the lung: with special reference to CK14 overexpression in cancer of high-proliferative and lymphogenous metastatic potential.
Tsubokawa F; Nishisaka T; Takeshima Y; Inai K
Pathol Int; 2002 Apr; 52(4):286-93. PubMed ID: 12031084
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas.
Shastry AH; Thota B; Srividya MR; Arivazhagan A; Santosh V
Pathol Oncol Res; 2016 Apr; 22(2):287-92. PubMed ID: 26253838
[TBL] [Abstract][Full Text] [Related]
16. Keratin expression in breast cancers.
Shao MM; Chan SK; Yu AM; Lam CC; Tsang JY; Lui PC; Law BK; Tan PH; Tse GM
Virchows Arch; 2012 Sep; 461(3):313-22. PubMed ID: 22851038
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of GFAP, vimentin and cytokeratins in GL-15 glioblastoma cell line.
Perzelcová A; Máciková ; Tardy M; Mráz P; Steno J; Bízik I
Neoplasma; 2000; 47(6):362-6. PubMed ID: 11263860
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and immunohistochemical study of 39 cases of Adenomatoid Odontogenic Tumour: a multicentric study.
Leon JE; Mata GM; Fregnani ER; Carlos-Bregni R; de Almeida OP; Mosqueda-Taylor A; Vargas PA
Oral Oncol; 2005 Sep; 41(8):835-42. PubMed ID: 15979930
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of cytokeratins expressed in the adult human cornea, limbus and perilimbal conjunctiva.
Merjava S; Neuwirth A; Tanzerova M; Jirsova K
Histol Histopathol; 2011 Mar; 26(3):323-31. PubMed ID: 21210345
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 expression and prognostic impact in glioblastoma.
Nduom EK; Wei J; Yaghi NK; Huang N; Kong LY; Gabrusiewicz K; Ling X; Zhou S; Ivan C; Chen JQ; Burks JK; Fuller GN; Calin GA; Conrad CA; Creasy C; Ritthipichai K; Radvanyi L; Heimberger AB
Neuro Oncol; 2016 Feb; 18(2):195-205. PubMed ID: 26323609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
